GINA MEDICS LTD

Company Registration Number:
13144274 (England and Wales)

Unaudited micro entity accounts for the year ended 31 January 2025

Period of accounts

Start date: 01 February 2024

End date: 31 January 2025

GINA MEDICS LTD

Contents of the Financial Statements

for the Period Ended 31 January 2025

Company Information - 3
Balance sheet - 4
Footnotes to the Balance Sheet - 6

GINA MEDICS LTD

Company Information

for the Period Ended 31 January 2025




Registered office: 6
Brambling Crescent
Harlow
Essex
GBR
CM17 0GF
Company Registration Number: 13144274 (England and Wales)

GINA MEDICS LTD

Balance sheet

As at 31 January 2025


2025
£

2024
£
Fixed Assets: 5,976 7,287
Current assets: 6,556 4,652
Creditors: amounts falling due within one year: ( 1,263 ) ( 1,280 )
Net current assets (liabilities): 5,293 3,372
Total assets less current liabilities: 11,269 10,659
Creditors: amounts falling due after more than one year: ( 1,386 ) ( 1,386 )
Total net assets (liabilities): 9,883 9,273
Capital and reserves: 9,883 9,273

GINA MEDICS LTD

Balance sheet continued

For the year ending 31 January 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 2 April 2025
And Signed On Behalf Of The Board By:

Name: Ugochukwu Obumneke AKWAZIE
Status: Director

The notes form part of these financial statements

GINA MEDICS LTD

Footnotes to the Financial Statements

for the Period Ended 31 January 2025

  • 1. Employee Information

    Average number of employees: 1

GINA MEDICS LTD

Footnotes to the Financial Statements

for the Period Ended 31 January 2025

  • 2. Off balance sheet disclosure

    No